Antigens and antibodies

BW Bo Wang
BD Brandon J. DeKosky
MT Morgan R. Timm
JL Jiwon Lee
EN Erica Normandin
JM John Misasi
RK Rui Kong
JM Jonathan R. McDaniel
GD George Delidakis
KL Kendra E. Leigh
TN Thomas Niezold
CC Chang W. Choi
EV Elise G. Viox
AF Ahmed Fahad
AC Alberto Cagigi
AP Aurélie Ploquin
KL Kwanyee Leung
EY Eun S. Yang
WK Wing-Pui Kong
WV William N. Voss
AS Aaron G. Schmidt
MM M. Anthony Moody
DA David R. Ambrozak
AH Amy R. Henry
FL Farida Laboune
JL Julie E. Ledgerwood
BG Barney S. Graham
MC Mark Connors
DD Daniel C. Douek
NS Nancy J. Sullivan
AE Andrew D. Ellington
JM John R. Mascola
GG George Georgiou
request Request a Protocol
ask Ask a question
Favorite

Recombinant Ebola virus glycoprotein with the mucin-like domain deleted (GPΔmuc), and HIV-1 fusion peptide probe (VRC34-epitope scaffold-FP) and knock-out scaffold probe (VRC34-epitope scaffold-KO) were produced as described previously19,31,32. Proteins were biotinylated and conjugated with streptavidin-APC (GPΔmuc and VRC34-epitope scaffold-FP) or streptavidin-PE (VRC34-epitope scaffold-KO) (Thermo Fisher Scientific), respectively. Recombinant hemagglutinins (A/California/07/2009, A/Solomon Islands/3/2006, and A/Wisconsin/67/2005) were produced as before33 or acquired from BEI Resources (A/Victoria/210/2009, and B/Brisbane/60/2008) and were biotinylated using an EZ-Link Sulfo-NHS-LC-Biotin kit (Thermo Fisher Scientific). Anti-flag FITC antibody was purchased from Sigma-Aldrich (clone M2).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A